Novo Nordisk Inc Company Profile
✉ Email this page to a colleague
Biologic Drugs for Novo Nordisk Inc
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Patent No. | Estimated Patent Expiration | Source |
---|---|---|---|---|---|---|---|
Novo Nordisk Inc. | NOVOLIN R | insulin human | Injection | 019938 | 10,004,686 | 2025-05-23 | Patent claims search |
Novo Nordisk Inc. | NOVOLIN R | insulin human | Injection | 019938 | 10,220,075 | 2034-12-02 | Patent claims search |
Novo Nordisk Inc. | NOVOLIN R | insulin human | Injection | 019938 | 10,220,076 | 2034-05-15 | Patent claims search |
Novo Nordisk Inc. | NOVOLIN R | insulin human | Injection | 019938 | 10,259,856 | 2028-03-18 | Patent claims search |
Novo Nordisk Inc. | NOVOLIN R | insulin human | Injection | 019938 | 10,272,050 | 2034-10-14 | Patent claims search |
Novo Nordisk Inc. | NOVOLIN R | insulin human | Injection | 019938 | 10,307,464 | 2040-04-01 | Patent claims search |
Novo Nordisk Inc. | NOVOLIN R | insulin human | Injection | 019938 | 10,307,551 | 2028-09-26 | Patent claims search |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Patent No. | >Estimated Patent Expiration | >Source |
Similar Applicant Names
This search can help find similar names.